Part 3 This slide reviews recommendations for the frequency of A1C testing from the 2015 ADA guidelines. Refer to source document for full recommendations,

Slides:



Advertisements
Similar presentations
Management of Diabetes Treat to Target Approach (A1c
Advertisements

Emergency Care Part 2: Treating and Preventing Hypoglycaemia
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Diabetes in Pregnancy Screening.
Rattan Juneja MD¹; Michael E. Stuart, MD 2,3 ; Sheri A. Strite 3 Indiana University School of Medicine, Indianapolis, Indiana¹ University of Washington,
Diabetes in the 21 st Century 2010 Update. American Diabetes Association 2010 Guidelines – Diagnostic Criteria A1C > or = 6.5% is included as diagnostic.
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?
carb counting with lenny Mean plasma glucose A1C (%)mg/dLmmol/L Correlation of.
The Value of Medication Therapy Management Services.
State of New Hampshire Pharmacy Benefit Changes Effective November 1, 2011 Presented By: Melisa Briggs.
Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia Part 1.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
ERECTILE DYSFUNCTION 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
1 Module 7 Discharge Planning Managing the Transition from Inpatient to Outpatient Care Diabetes Special Interest Group Georgia Hospital Association.
DIABETES IN THE ELDERLY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Thiazide diuretics, Potassium, and the Development of Diabetes A Quantitative Review Hypertension2006_219.
 SC Guidelines for Diabetes Care Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.
Focus on Nursing Pharmacology
BDH Discovering Tomorrow’s Healthcare Solutions Today Clinical Research Services, Inc. Basil Halliday, M.Sc. President & CEO BDH Clinical Research Services.
Berkshire Weight Loss Surgery Royal Berkshire Hospital, Reading James Ramus, Consultant UGI & Bariatric Suregon.
Bariatric Surgery for T2DM The STAMPEDE Trial. A.R. BMI 36.5 T2DM diagnosed age 24 On Metformin, glyburide  insulin Parents with T2DM, father on dialysis.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Insulin Therapy for Type 2 Diabetes Mellitus JAMA.
A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Clerk 陳威任.
CHANGES in ada 2015.
Redefining Quality Care in T2DM Patients with CV Disease
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
2012 ADA Clinical Practice Guidelines Therapies for DM- Type 2
Actions Outcomes Resulting from Positive Hemoglobin A1C Screenings
Where we have been, where we need to be
Treatment algorithm for management of type 2 diabetes mellitus
Chronic Disease Under Control: Diabetes and Hypertension
Intensive Statin Recommendations
ĐÁI THÁO ĐƯỜNG VÀ THAI KỲ
Tribal Endocrinology teleECHO Clinic Pilot 2018
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Hemoglobin A1c Targets for Glycemic Controls
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Treat to Target in Gout.
Updates to Managing Diabetes in the Long-Term Care Setting
Sodium-glucose co-transporter 2 (SGLT2) inhibitors work by blocking the reabsorption of filtered glucose in the kidneys. This leads to glucosuria and improved.
مسئولیتهای پزشکی درانجام اقدامات تشخیصی و درمانی (رابطه حقوقی پزشک و بیمار)
دکتر سعید غلامزاده مدیرکل پزشکی قانونی استان فارس
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Current Therapy for Type II Diabetes
A New Chapter for CV Risk Management in Diabetes - Challenges & Opportunities.
Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA
Antihyperglycemic therapy in type 2 diabetes: general recommendations
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.
Key Insulin Side Effects*
Part 1 This slide reviews criteria for diabetes diagnosis from the 2015 ADA guidelines. Refer to source document for full recommendations, including level.
Evaluating BTK Inhibitors in CLL
Update on OTC Pain Relievers for Osteoarthritis
Pharmaceutical care planning 2 Ola Ali Nassr
Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA
Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.
Rational Pharmacotherapy Selection for Insomnia
Part 2.
Chronic Disease Under Control: Managed Care Plan Distribution, 2006
Assessing Diabetes Care at the Cornell Scott-Hill Health Center
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.
PowerPoint 16:9 Screen Ratio Template *
Built Environment to Promote Physical Activity: Supplemental Slides
Part 4 This slide reviews recommendations for antiplatelet therapy from the 2015 ADA guidelines. Refer to source document for full recommendations, including.
A1C at baseline, 16 weeks, and 32 weeks according to study group in all participants (A), adult participants (B), and adolescent participants (C) who returned.
Guideline approach to drug therapy in newly diagnosed type 2 diabetic patients not at target. Guideline approach to drug therapy in newly diagnosed type.
ვ. ივერიელის სახელობის ენდოკრინოლოგია-
Presentation transcript:

Part 3 This slide reviews recommendations for the frequency of A1C testing from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide shows the correlation of A1C with average glucose from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide shows glycemic targets for nonpregnant adults with diabetes from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide reviews criteria for individualizing glycemic targets for adults with diabetes from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide reviews criteria for managing hypoglycemia in diabetes from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide reviews recommended pharmacologic therapy for treating and managing type 1 diabetes from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 Any pharmacologic agents discussed are approved for use in the United States by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual prescribing information for approved uses outside of the United States. This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide reviews recommended pharmacologic therapy for treating and managing type 2 diabetes from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 Any pharmacologic agents discussed are approved for use in the United States by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual prescribing information for approved uses outside of the United States. This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide reviews recommendations for bariatric surgery from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide reviews recommendations for treating and managing hypertension in individuals with diabetes from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 Any pharmacologic agents discussed are approved for use in the United States by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual prescribing information for approved uses outside of the United States. This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.

This slide reviews recommendations for treating and managing dyslipidemia in individuals with diabetes from the 2015 ADA guidelines. Refer to source document for full recommendations, including level of evidence rating. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1-S93. January 2014 This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.